This study, called "PrEPare for Work," is testing a new approach to help male sex workers start and stick with PrEP (pre-exposure prophylaxis), a medication that prevents HIV. The study will involve about 500 participants and is currently unclear if it's recruiting. It has two main parts: first, a trained case manager will help you get connected to doctors who can prescribe PrEP. Second, once you have PrEP, you'll receive one-on-one counseling and daily text messages to help you take it regularly. The study will measure how many people start PrEP after two months and how well they take it after 12 months. To join, you must be a man aged 18 or older, have had condomless anal sex with another man in the past three months, and have exchanged sex for money or other items with another man in the past three months. You also can't be currently taking PrEP and must be HIV-negative or unsure of your status.

Study design

This is an interventional study, meaning participants will receive a specific intervention. It is a randomized controlled trial (RCT) and plans to enroll 500 participants.

What's involved

Participants will receive a trained case manager to help with PrEP linkage and three weekly adherence intervention sessions. Personalized daily text message reminders will also be provided.

Compensation

Not stated in the trial record.

Follow-up

PrEP initiation will be measured at 2 months post Stage 1 randomization, and PrEP adherence will be measured at 12 months post Stage 2 randomization.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.